CV
CV Sciences, Inc.
CVSI · OTC
$0.02 -0.63% (-$0.00)
1M -18.89%
Market Cap $3.87M
P/E Ratio -
Div. Yield -
ROE 132.06%
Bulios Fair Price
$0.02
6.0% upside
Current Price
$0.019
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CVSI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
88 /100
Cheap P/B 2.46x
P/S 0.30x
PEG N/A
Growth
0 /100
Declining Rev. growth 5.24%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 4.10%
Op. margin 11.70%
Gross margin 49.14%
Quality
15 /100
Poor Asset turnover 1.95x
ROA 30.76%
ROIC 52.85%
Debt
38 /100
Moderate Current ratio 0.99x
Int. coverage -4.52x
Debt/Equity 0.80x
Stability
49 /100
Moderate Profitable years 0
EPS volatility 157.42%
Beta 0.49x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVSI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Joseph D. Dowling
Employees
43
Headquarters
San Diego
Upcoming events
16 NOV
Earnings
Upcoming earnings report